
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data
Amgen Inc. AMGN reported first-quarter sales of $8.15 billion on Thursday, up 9% year over year and beating the consensus of $8.06 billion. Product sales grew 11%, primarily driven by 14% volume growth, partially offset by 6% lower net selling price. U.S. …